BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,123 | -35.3% | 6,866 | -21.9% | 0.01% | -14.3% |
| Q2 2023 | $400,668 | +21.1% | 8,794 | +7.8% | 0.01% | +40.0% |
| Q1 2023 | $330,929 | -19.5% | 8,159 | +1.1% | 0.01% | -16.7% |
| Q4 2022 | $411,241 | +8.8% | 8,068 | +15.2% | 0.01% | 0.0% |
| Q3 2022 | $378,000 | +8.9% | 7,003 | +29.6% | 0.01% | +20.0% |
| Q2 2022 | $347,000 | -24.4% | 5,403 | -8.7% | 0.01% | -16.7% |
| Q1 2022 | $459,000 | -24.6% | 5,916 | -16.6% | 0.01% | -40.0% |
| Q4 2021 | $609,000 | +8.6% | 7,096 | +1.8% | 0.01% | +42.9% |
| Q3 2021 | $561,000 | +11.5% | 6,972 | +11.5% | 0.01% | +16.7% |
| Q2 2021 | $503,000 | -0.4% | 6,254 | +4.4% | 0.01% | -14.3% |
| Q1 2021 | $505,000 | +1.6% | 5,993 | -3.2% | 0.01% | 0.0% |
| Q4 2020 | $497,000 | -11.1% | 6,193 | -10.9% | 0.01% | -22.2% |
| Q3 2020 | $559,000 | -1.2% | 6,951 | +5.7% | 0.01% | -18.2% |
| Q2 2020 | $566,000 | +1.1% | 6,579 | -4.5% | 0.01% | -21.4% |
| Q1 2020 | $560,000 | -20.7% | 6,892 | -18.4% | 0.01% | +7.7% |
| Q4 2019 | $706,000 | +12.8% | 8,441 | +17.9% | 0.01% | +8.3% |
| Q3 2019 | $626,000 | +4.0% | 7,162 | -2.5% | 0.01% | -40.0% |
| Q2 2019 | $602,000 | +2.6% | 7,346 | +1.8% | 0.02% | -13.0% |
| Q1 2019 | $587,000 | +37.5% | 7,217 | +11.1% | 0.02% | +27.8% |
| Q4 2018 | $427,000 | -27.7% | 6,496 | -15.3% | 0.02% | -14.3% |
| Q3 2018 | $591,000 | +11.5% | 7,671 | +6.9% | 0.02% | +5.0% |
| Q2 2018 | $530,000 | -1.5% | 7,176 | -13.3% | 0.02% | -4.8% |
| Q1 2018 | $538,000 | +0.2% | 8,276 | -0.3% | 0.02% | +5.0% |
| Q4 2017 | $537,000 | -47.0% | 8,305 | -48.6% | 0.02% | -48.7% |
| Q3 2017 | $1,013,000 | -4.8% | 16,144 | -8.2% | 0.04% | -7.1% |
| Q2 2017 | $1,064,000 | +9.0% | 17,583 | -6.6% | 0.04% | +7.7% |
| Q1 2017 | $976,000 | +9.8% | 18,823 | -6.1% | 0.04% | +5.4% |
| Q4 2016 | $889,000 | -34.2% | 20,043 | -29.4% | 0.04% | -32.7% |
| Q3 2016 | $1,352,000 | +9.7% | 28,398 | +4.1% | 0.06% | +10.0% |
| Q2 2016 | $1,233,000 | -6.6% | 27,268 | -15.2% | 0.05% | -7.4% |
| Q1 2016 | $1,320,000 | -1.4% | 32,138 | -8.4% | 0.05% | +1.9% |
| Q4 2015 | $1,339,000 | -39.1% | 35,093 | -47.6% | 0.05% | -37.6% |
| Q3 2015 | $2,200,000 | -79.8% | 66,982 | -56.9% | 0.08% | -76.4% |
| Q2 2015 | $10,871,000 | -11.0% | 155,451 | -12.9% | 0.36% | -8.6% |
| Q1 2015 | $12,219,000 | -4.3% | 178,390 | +2.4% | 0.39% | -4.6% |
| Q4 2014 | $12,768,000 | – | 174,207 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |